The Business Research Company Global Breast Cancer Diagnostics Market Report 2022 – Market Size, Trends and Global Forecast 2022-2026
LONDON, GREATER LONDON, UK, September 21, 2022 /EINPresswire.com/ — According to The Business Research Company’s 2022 Global Breast Cancer Diagnostics Market Report, the breast cancer diagnostics market is expected to grow from $3.75 billion in 2021 to $4.06 billion in 2022 with a compound annual growth rate (CAGR) of 8.3%. , According to TBRC Market outlook for breast cancer diagnostics the market is then expected to grow to $5.48 billion in 2026 at a CAGR of 7.8%. The rising incidence of breast cancer will require more diagnostic equipment, which will further increase the demand for the breast cancer diagnostic market.
Request a sample now to better understand the breast cancer diagnostics market:
Key Trends in the Breast Cancer Diagnostics Market
Technological advancement is a key trend in the breast cancer diagnostics market. Several new methods have been developed that can be used to diagnose and treat breast cancer. 3D mammography, also known as breast tomosynthesis, takes pictures of the breasts from different angles and translates them into a 3D model.
Market Overview of Breast Cancer Diagnostics
The breast cancer diagnostic market consists of sales of breast cancer diagnostic devices and related services by entities (organizations, individuals and partnerships) that manufacture breast cancer diagnostic devices. These devices are used to diagnose breast cancer. Only goods and services sold between organizations or sold to end consumers are included.
Learn more about the Global Breast Cancer Diagnostics Market Report at:
TBRC’s 2022 Global Breast Cancer Diagnostics Market Report contains the following information:
Market size data
• Forecast period: historical and future
• By region: Asia Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• By country: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
• By type: imaging, biopsy, genomic tests, blood tests, others
• By technology: fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), immunohistochemical (IHC), others
• By type of cancer: BRCA breast cancer, ER and PR breast cancer, HER 2 breast cancer, EGFR mutation test breast cancer, others
• By type of diagnosis: ionizing breast imaging technologies, non-ionizing imaging technologies
• By end user: hospitals and clinics, cancer research centers, diagnostic laboratories, outpatient surgical centers.
• Geographically: The global breast cancer diagnostics market is segmented into North America, South America, Asia Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America holds the largest market share.
Major market players such as Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips NV, Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc, Siemens AG, NanoString Technologies Inc and CR Bard Inc.
Trends, opportunities, strategies and more.
The 2022 Global Breast Cancer Diagnostics Market Report is one of The Business Research Company’s comprehensive reports that provides an overview of the breast cancer diagnostics market. The Market Report provides analysis of the Global Breast Cancer Diagnostics Market, Global Breast Cancer Diagnostics Market Size, Global Breast Cancer Diagnostics Market Growth Drivers, Global Breast Cancer Diagnostics Market Segments, Major Players of the Global Breast Cancer Diagnostics Market, Global Market Growth breast cancer diagnostics by geographic region, revenue and market positioning of competitors in the breast cancer diagnostics market. The Global Breast Cancer Diagnostics Market Research Report allows you to gain insight into opportunities and strategies, as well as identify countries and segments with the highest growth potential.
Not what you were looking for? View similar reports from The Business Research Company:
Breast Imaging Device Market 2022
2022 Global Breast Cancer Monoclonal Antibody Market Report
Global Cancer Clinical Decision Tools Market Report 2022
About the business research company
Business Research has published over 3,000 industry reports covering over 3,000 market segments and 60 regions. The reports are based on 150,000 data sets, extensive secondary research and exclusive insights from interviews with industry leaders. The reports are supplemented with detailed analysis of the impact of COVID-19 on various markets.
Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
America: +1 315 623 0293
Email: [email protected]
Check out our:
Blog TBRK: http://blog.tbrc.info/
Global market model: https://www.thebusinessresearchcompany.com/global-market-model
Market research of products, services and solutions for your business – TBRC